Royce & Associates LP Maravai Lifesciences Holdings, Inc. Transaction History

Royce & Associates LP

$9.35 Billion
Q3 2025

A detailed history of Royce & Associates LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 1,761,764 shares of MRVI stock, worth $6.41 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,761,764

Previous 1,276,856 37.98%

Holding current value

$6.41 Million

Previous $3.08 Million 64.32%

% of portfolio

0.05%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$2.03 - $2.89 $984,363 - $1.4 Million	484,908 Added 37.98%	1,761,764 $5.06 Million
Q2 2025 Aug 11, 2025	SELL	$1.72 - $2.47 $88,731 - $127,422	-51,588 Reduced 3.88%	1,276,856 $3.08 Million
Q1 2025 May 06, 2025	BUY	$2.21 - $6.13 $816,725 - $2.27 Million	369,559 Added 38.54%	1,328,444 $2.94 Million
Q4 2024 Feb 10, 2025	BUY	$4.42 - $8.5 $221,472 - $425,909	50,107 Added 5.51%	958,885 $5.23 Million
Q3 2024 Nov 06, 2024	BUY	$6.84 - $9.73 $3.52 Million - $5 Million	514,332 Added 130.39%	908,778 $7.55 Million

Q2 2024 Aug 13, 2024	BUY	$6.87 - $11.34 $2.6 Million - $4.29 Million	378,009 Added 2299.74%	394,446 $2.82 Million
Q1 2024 May 13, 2024	BUY	$5.11 - $8.76 $83,993 - $143,988	16,437 New	16,437 $142,000
Q4 2022 May 23, 2023	BUY	$12.5 - $24.78 $676,325 - $1.34 Million	54,106 New	54,106 $774,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $676,325 - $1.34 Million	54,106 New	54,106 $774,000
Q2 2022 Aug 04, 2022	BUY	$26.05 - $37.48 $2.85 Million - $4.1 Million	109,303 Added 31.28%	458,788 $13 Million
Q1 2022 May 05, 2022	BUY	$24.46 - $40.92 $8.55 Million - $14.3 Million	349,485 New	349,485 $12.3 Million

Others Institutions Holding MRVI

# of Institutions

182

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Maravai Lifesciences Holdings, Inc. Transaction History